Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutant p53 in patients with invasive cervical cancer stages IB to IIB.

Gynecologic oncology - 1 May 1995

Kainz C, Kohlberger P, Gitsch G, Sliutz G, Breitenecker G, Reinthaller A

Abstract excerpt

The present study evaluates the prognostic value of mutant p53 protein overexpression in 109 surgically treated cervical cancer stages IB to IIB. Squamous cell carcinoma stages IB, IIA, and IIB were present in 52, 13, and 44 cases, respectively. We performed immunohistochemistry using a monoclonal antibody against the p53 suppressor gene product (clone BP53-12). Data were analyzed for the end points of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, p53

Share to Mutation

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 7729736
DOI: 10.1006/gyno.1995.1127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutant p53 in patients with invasive cervical cancer stages IB to IIB.PMID 7729736Read ↗

Mutant p53 product in patients with stage III cervical cancer.Semantic proximity Read ↗

p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis.Semantic proximity Read ↗

p53 alterations in all stages of breast cancer.Semantic proximity Read ↗

Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.Semantic proximity Read ↗

p53 overexpression as a prognostic indicator in endometrial carcinoma.Semantic proximity Read ↗

Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer.Semantic proximity Read ↗

Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.Semantic proximity Read ↗

p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.Semantic proximity Read ↗

Mutant p53 protein in the serum of patients with cervical carcinoma: correlation with the level of serum epidermal growth factor receptor and prognostic significance.Semantic proximity Read ↗

Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.Semantic proximity Read ↗

Maintenance of p53 alterations throughout breast cancer progression.Semantic proximity Read ↗

p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.